The NIH study confirms in vitro, the hypotheses described by Riordan et al in “Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent”:
· Tumor cells are more susceptible to the effects of high-dose, ascorbate-induced peroxidation products because of a relative catalase deficiency.
· Concentrations of ascorbate high enough to kill tumor cells can be achieved in humans.
· Vitamin C was an effective anti-tumor therapy as long as high enough concentrations of it could be achieved inside the tumor(s).
· Since cancer patients are often depleted of vitamin C, replenishment may improve immune system function and enhance patient health and well-being.
· High dose IVC is a non-toxic chemotherapeutic agent that can be given in conjunction with conventional cancer treatments and when is administered in high doses by intravenous (I.V.) infusions, can kill cancer cells.
Please complete all fields to make an appointment request . All fields are required *